Kumrah Rajni, Vignesh Pandiarajan, Patra Pratap, Singh Ankita, Anjani Gummadi, Saini Poonam, Sharma Madhubala, Kaur Anit, Rawat Amit
Allergy Immunology Unit, Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Genes Dis. 2019 Jul 24;7(1):52-61. doi: 10.1016/j.gendis.2019.07.004. eCollection 2020 Mar.
Severe Combined Immunodeficiency (SCID) is an inherited group of rare, life-threatening disorders due to the defect in T cell development and function. Clinical manifestations are characterised by recurrent and severe bacterial, viral, and fungal opportunistic infections that start from early infancy period. Haematopoietic stem cell transplantation (HSCT) is the treatment of choice. The pattern of inheritance of SCID may be X-linked or autosomal recessive. Though the diagnosis of SCID is usually established by flow cytometry-based tests, genetic diagnosis is often needed for genetic counselling, prognostication, and modification of pre-transplant chemotherapeutic agents. This review aims to highlight the genetic aspects of SCID.
重症联合免疫缺陷(SCID)是一组由于T细胞发育和功能缺陷导致的遗传性罕见且危及生命的疾病。临床表现的特征是从婴儿早期开始反复发生严重的细菌、病毒和真菌机会性感染。造血干细胞移植(HSCT)是首选的治疗方法。SCID的遗传模式可能是X连锁或常染色体隐性遗传。虽然SCID的诊断通常通过基于流式细胞术的检测来确立,但为了进行遗传咨询、预后评估以及调整移植前化疗药物,往往需要进行基因诊断。本综述旨在突出SCID的遗传学方面。